Brief: Celularity Announces Multi-Year Research Collaboration Services Agreement With Regeneron
Aug 29 (Reuters) - Celularity Inc CELU.O :
* CELULARITY ANNOUNCES MULTI-YEAR RESEARCH COLLABORATION
SERVICES
AGREEMENT WITH REGENERON
* CELULARITY INC: TO PROVIDE RESEARCH SUPPORT FOR
REGENERON'S
TARGETED, ALLOGENEIC, CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL
THERAPY
* CELULARITY INC: FINANCIAL TERMS OF AGREEMENT WERE NOT
DISCLOSED
* CELULARITY INC: RESEARCH WILL TAKE PLACE AT CO'S FACILITY
LOCATED IN FLORHAM PARK, N.J.
Further company coverage: CELU.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Celularity
See all newsU.S. STOCKS ON THE MOVE-BWX Technologies, Synopsys,Burlington Stores
U.S. STOCKS ON THE MOVE-Jazz Pharmaceuticals, Celularity, Infleqtion
Celularity hits over 4-month high on deal to manufacture MuseCell's cell therapy platform
Celularity rises on deal to manufacture MuseCell's cell therapy platform
Brief: Celularity And MuseCell Innovations® Announce U.S. Manufacturing Collaboration For The Dezawa Musecell® Platform